173
Participants
Start Date
June 30, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
4mm x 32G pen needle
For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were advised to inject straight in when using the 4mm PN, with no pinch up.
8mm x 31G pen needle
For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were directed to use pinch-up when injecting in the abdomen or thigh with the 8mm PN, and no pinch-up at other injection sites.
5mm x 31G pen needle
For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were advised to inject straight in when using the 5mm PN, with no pinch up.
Atlanta Diabetes Associates, Atlanta
Radiant Research, Birmingham
AMCR Institute, Inc., Escondido
Rainier Clinical Research Center, Inc., Renton
Lead Sponsor
Becton, Dickinson and Company
INDUSTRY